BRIACELL THERAPEUTICS CORP. (BCTXZ) Net income 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXZ) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$34.9MFY2026 · since FY2021: -$13.8M → -$34.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$34.9M | -32.7% |
| FY2025 | -$26.3M | -449.1% |
| FY2024 | -$4.8M | +76.4% |
| FY2023 | -$20.3M | +24.4% |
| FY2022 | -$26.8M | -94.3% |
| FY2021 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXZ financial trends
BCTXZ RevenueBCTXZ Net marginBCTXZ Gross profitBCTXZ Gross marginBCTXZ Operating incomeBCTXZ Operating marginBCTXZ Operating cash flowBCTXZ Free cash flowBCTXZ Capital expendituresBCTXZ Return on equityBCTXZ Stock buybacksBCTXZ Dividends paidBCTXZ Total assetsBCTXZ Total liabilitiesBCTXZ Shareholders’ equityBCTXZ overview →